Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Bluebird Bio, Inc. (BLUE)  
$0.92 0.01 (1.13%) as of 4:30 Fri 4/26


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 139,126,000
Market Cap: 128.39(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.9052 - $5.03
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   bluebird bio is a company focused on the pursuit of curative gene therapies for severe genetic diseases. Co. has late-stage clinical and research programs for the treatment of sickle cell disease (SCD), ss-thalassemia and cerebral adrenoleukodystrophy and is developing research to apply new technologies to these and other diseases. Using a proprietary lentiviral vector platform, Co. custom designs each of its therapies to address the underlying cause of disease by introducing a functional copy of a gene to patients' own isolated hematopoietic stem cells. Co. is developing lovotibeglogene autotemcel as a one-time treatment for patients with SCD.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 27,248 35,533 57,514 116,582
Total Sell Value $35,492 $61,294 $139,194 $443,003
Total People Sold 4 5 5 9
Total Sell Transactions 6 9 12 23
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 939
  Page 10 of 38  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Finger Alison Cecily Chief Commercial Officer   •       –      –    2020-01-03 4 S $84.96 $43,924 D/D (517) 19,197 36%     
   Wentworth Kory James Principal Accounting Officer   •       –      –    2019-12-19 4 S $92.59 $36,758 D/D (397) 6,449     -
   Gregory Philip D Chief Scientific Officer   •       –      –    2019-12-17 4 AS $94.31 $169,749 D/D (1,800) 29,092     -
   Gregory Philip D Chief Scientific Officer   •       –      –    2019-12-17 4 OE $50.51 $90,918 D/D 1,800 30,892     -
   Gregory Philip D Chief Scientific Officer   •       –      –    2019-12-05 4 AS $80.57 $20,143 D/D (250) 29,092     -
   Gregory Philip D Chief Scientific Officer   •       –      –    2019-11-05 4 AS $81.95 $20,488 D/D (250) 29,342     -
   Gregory Philip D Chief Scientific Officer   •       –      –    2019-10-07 4 AS $89.07 $22,267 D/D (250) 29,592     -
   Sellers William R. Director   –       •      –    2019-09-25 4 A $0.00 $0 D/D 2,000 2,000     -
   Davidson David Chief Medical Officer   •       –      –    2019-09-10 4 AS $100.16 $206,324 D/D (2,060) 31,616     -
   Davidson David Chief Medical Officer   •       –      –    2019-09-10 4 OE $50.51 $104,051 D/D 2,060 33,676     -
   Davidson David Chief Medical Officer   •       –      –    2019-09-09 4 AS $100.11 $300,340 D/D (3,000) 31,616     -
   Davidson David Chief Medical Officer   •       –      –    2019-09-09 4 OE $50.51 $151,530 D/D 3,000 34,616     -
   Gregory Philip D Chief Scientific Officer   •       –      –    2019-09-05 4 AS $101.20 $86,018 D/D (850) 29,842     -
   Gregory Philip D Chief Scientific Officer   •       –      –    2019-09-05 4 OE $50.51 $30,306 D/D 600 30,692     -
   Walsh Jeffrey T. Chief Strategy Officer   •       –      –    2019-08-20 4 AS $124.00 $62,000 D/D (500) 40,921     -
   Walsh Jeffrey T. Chief Strategy Officer   •       –      –    2019-08-20 4 OE $24.47 $12,235 D/D 500 41,421     -
   Gregory Philip D Chief Scientific Officer   •       –      –    2019-08-08 4 AS $124.03 $117,824 D/D (950) 30,092     -
   Gregory Philip D Chief Scientific Officer   •       –      –    2019-08-08 4 OE $75.60 $52,920 D/D 700 31,042     -
   Davidson David Chief Medical Officer   •       –      –    2019-08-06 4 AS $115.25 $587,389 D/D (5,060) 31,616     -
   Davidson David Chief Medical Officer   •       –      –    2019-08-06 4 OE $50.51 $255,581 D/D 5,060 36,676     -
   Gregory Philip D Chief Scientific Officer   •       –      –    2019-08-05 4 AS $116.79 $99,393 D/D (850) 30,342     -
   Gregory Philip D Chief Scientific Officer   •       –      –    2019-08-05 4 OE $50.51 $30,306 D/D 600 31,192     -
   Gregory Philip D Chief Scientific Officer   •       –      –    2019-07-05 4 AS $128.27 $232,426 D/D (1,800) 30,592     -
   Gregory Philip D Chief Scientific Officer   •       –      –    2019-07-05 4 OE $50.51 $83,226 D/D 1,300 32,392     -
   Davidson David Chief Medical Officer   •       –      –    2019-07-05 4 AS $128.28 $991,748 D/D (7,660) 31,616     -
  939 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 10 of 38
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us